WESTON, FL -- (Marketwire) -- 01/14/10 -- Wall Street News Alert's "stocks to watch" this morning are: Wound Management Technologies, Inc. (OTCBB: WNDM), Merck & Co., Inc. (NYSE: MRK), Nektar Therapeutics (NASDAQ: NKTR) and CVS Caremark Corporation (NYSE: CVS).
Yesterday after the markets closed, Wound Management Technologies, Inc. (OTCBB: WNDM), issued a press release announcing that it is nearing the completion of its registration of CellerateRX in Mexico and has identified its first distributor in that country. Numerous physicians in the nation have already evaluated the Activated Collagen wound care product and were impressed with its speed and efficacy in the management of diabetic ulcers and are optimistic that it will play a tremendous role in the management of these types of wounds.
CellerateRX® is FDA cleared for acute and chronic wounds which include but are not limited to: diabetic ulcers, venous stasis ulcers, ulcers due to arterial insufficiency, pressure ulcers stages I-IV, surgical wounds, traumatic wounds, superficial wounds, and 1st and 2nd degree burns. It comes in two forms, a powder which is about 95% collagen, and a gel which is about 65% collagen, and contains no additives or synthetics. CellerateRX® is manufactured in the United States. "Several independently run evidence-based studies have certified our product's value, and the overwhelmingly positive data can now be accessed at www.woundmanagementtechnologies.com," said Cathy Bradshaw, President of Wound Care Innovations, the division that markets CellerateRX.
Demand for the product continues to grow in the Middle East as new orders are received; the product is also poised for distribution in South East Asia and South America upon completion of the necessary registrations. "The fact that international recognition for CellerateRX is increasing is very encouraging and reinforces what we have believed for a long time and that is that we have the best product in the market for the management of diabetic wounds," said Deborah Jenkins Hutchinson, President of Wound Management Technologies, Inc.
The stock closed yesterday at $1.40 a share.
For an in-depth profile of Wound Management Technologies, visit http://www.wallstreetnewsalert.com/view-company-profiles.php?profile=WNDM_011210.
To receive FREE Mobile Stock Alerts formatted especially for your cell phone, text the word "press" in the subject line to 68494.
Merck & Co., Inc. (NYSE: MRK) up 3.6% on 25.3 million shares traded.
Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first.
Nektar Therapeutics (NASDAQ: NKTR) up 13.5% on 3.8 million shares traded.
Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms.
CVS Caremark Corporation (NYSE: CVS) up 1.2% on 11.4 million shares traded.
CVS Caremark is the largest provider of prescriptions in the nation.
The Treasury Department said Wednesday that the deficit last month totaled $91.85 billion, the largest December deficit on record. The figure was in line with economists' expectations.
Let Wall Street News Alert help advertise for your company using our effective awareness campaigns. If you're interested in telling your story, we can help. Contact us at firstname.lastname@example.org.
WSNA's email alert service is free to those investors who sign up on the WSNA home page. The alert service is designed to notify investors of often-overlooked stocks. Subscribers are introduced to Special Situation companies that have the potential of showing increased activity. The Wall Street News Alert home page has experienced over 200 million hits. To subscribe to this free service, visit the Wall Street News Alert home page at http://www.wallstreetnewsalert.com.
*** It has come to the attention of Wall Street News Alert (WSNA), that various persons or companies distribute faxes bearing similar names to Wall Street News Alert. Wall Street News Alert is not affiliated with faxes bearing names such as: Wall Street Stock Alert, Wall Street Investor Alert, Wall Street News Alert or any other fax using various combinations of the generic words Wall Street.***
Wall Street News Alert is a division of Wall Street Capital Funding LLC (WSCF). WSCF also maintains a contractual, working relationship with Stock Market Alerts LLC and its' Wall Street Enews brand. WSCF is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security. WSCF profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of WSCF and are subject to change without notice. Information in this release is derived from a variety of sources including that company's publicly disseminated information, third parties and WSCF research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. WSCF disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies' discussed in this release is highly speculative and carries a high degree of risk. WSCF is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in WSCF profiled stocks.
This profile is not without bias, and is a paid release. WSCF has been compensated for dissemination of company information on behalf of one or more of the companies mentioned in this release. For current services performed for Wound Management Technologies, Inc. (OTCBB: WNDM), WSCF has been compensated Fifteen Thousand Dollars, by third party, Everest Limited Inc., who are non-affiliated and may hold a significant position in the stock. WSCF holds no shares of the stock. WSCF may receive additional compensation for extension of its services. Any additional compensation will be disclosed at such time that WSCF is aware of a client's desire to extend the original services. WSCF may have received shares of a company profiled in this release prior to the dissemination of the information in this release. WSCF may immediately sell some or any shares in a profiled company held by WSCF and may have previously sold shares in a profiled company held by WSCF. WSCF's services for a company may cause the company's stock price to increase, in which event WSCF would make a profit when it sells its stock in a company. In addition, WSCF's selling of a company's stock may have a negative effect on the market price of the stock.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WSCF undertakes no obligation to update such statements.